As of November 2024 Inozyme Pharma has a market cap of A$0.31 Billion. This makes Inozyme Pharma the world's 7941th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 15th, 2024 the market cap of Inozyme Pharma was reported to be: